Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 03 04:00PM ET
5.49
Dollar change
+1.49
Percentage change
37.25
%
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand32.88M Perf Week-
Market Cap180.49M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-
Book/sh-0.16 P/B- EPS next Y- ROA- Short Interest- Perf Year-
Cash/sh0.00 P/C18049.00 EPS next 5Y- ROE- 52W Range- - - Perf YTD0.00%
Dividend Est.- P/FCF- EPS past 5Y17.63% ROI- 52W High- Beta-
Dividend TTM- Quick Ratio0.01 Sales past 5Y- Gross Margin- 52W Low- ATR (14)5.41
Dividend Ex-Date- Current Ratio0.01 EPS Y/Y TTM- Oper. Margin- RSI (14)- Volatility- -
Employees- Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q117.86% Payout- Rel Volume- Prev Close4.00
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume- Price5.49
SMA200.00% SMA500.00% SMA2000.00% Trades Volume2,246,508 Change37.25%
Jupiter Neurosciences, Inc. is a clinical stage research and development pharmaceutical company. Its therapeutic candidate, JOTROL is applicable to many central nervous system diseases, including Alzheimer's disease and traumatic brain injury. The company was founded by Christer Rosen, Alexander Rosen, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in June 2015 and is headquartered in Jupiter, FL.